The cytoplasmic expression of p-S6 has been shown to be a predictive factor for disease-free survival in hypopharyngeal [7] and laryngeal carcinomas [7,9] and in prostate adenocarcinoma [21], and it has been associated with smaller tumors in the oral cavity [8]. Here, RPS6 is linked to laryngeal carcinoma.